Anhui Anke BioTech Group300009
▲ ポジティブ需要関連度
Anke's subsidiary gains exclusive distribution rights for a unique pediatric drug, expanding market reach and revenue potential.
銘柄への影響 1
その他
Anhui Anke BioTech Groupテーマインパクト
カバレッジ外企業 3
安徽华胜非上場▲ ポジティブ
需要関連度
Anhui Huasheng, as the sole national distributor, directly gains from the exclusive rights and long-term cooperation.
合肥医工非上場▲ ポジティブ
需要関連度
Hefei Yigong, as the authorizing party, benefits from Anke's distribution network for its product.
合肥恩瑞特药业有限公司非上場▲ ポジティブ
需要関連度
Enruite, as the authorizing party, benefits from Anke's distribution capabilities for its product.